Tenax Therapeutics (TENX) Change in Inventory (2010 - 2014)
Tenax Therapeutics (TENX) reported Change in Inventory of -$97437.0 for Q2 2014, down 1215.61% on a YoY basis from $8734.0 in Q2 2013, and down 3163.13% sequentially from -$2986.0 in Q1 2014.
Tenax Therapeutics (TENX) Change in Inventory (2010 - 2014) Analysis & Trends
Tenax Therapeutics (TENX) has 5 years of Change in Inventory data on file, last reported at -$97437.0 in Q2 2014.
- For the quarter ending Q2 2014, Change in Inventory fell 1215.61% year-over-year to -$97437.0; the trailing twelve-month figure through Dec 2015 stood at -$100423.0 (changed N/A YoY), and the FY2014 full-year result was -$99204.0, down 390.43% from the prior year.
- Change in Inventory eased to -$97437.0 in Q2 2014, from -$2986.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $152048.0 in Q2 2011 to a low of -$97437.0 in Q2 2014.
- A 5-year average of $6957.1 and a median of $1185.0 in 2013 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory surged 111.37% in 2012 and plunged 1215.61% in 2014, its largest moves.
- Tracing TENX's Change in Inventory over 5 years: stood at -$45572.0 in 2010, then increased by 7.78% to -$42027.0 in 2011, then surged by 111.37% to $4780.0 in 2012, then plunged by 80.1% to $951.0 in 2013, then tumbled by 10345.74% to -$97437.0 in 2014.
- Business Quant data shows TENX's Change in Inventory at -$97437.0 in Q2 2014, -$2986.0 in Q1 2014, and $951.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2014 | -97,437.00 |
| Apr 30, 2014 | -97,437.00 |
| Jan 31, 2014 | -2,986.00 |
| Jan 31, 2014 | -2,986.00 |
| Oct 31, 2013 | 951.00 |
| Oct 31, 2013 | 951.00 |
| Jul 31, 2013 | 268.00 |
| Jul 31, 2013 | 268.00 |
| Apr 30, 2013 | 8,734.00 |
| Apr 30, 2013 | 8,734.00 |
| Jan 31, 2013 | 1,419.00 |
| Jan 31, 2013 | 1,419.00 |
| Oct 31, 2012 | 4,780.00 |
| Oct 31, 2012 | 4,780.00 |
| Jul 31, 2012 | -35,161.00 |
| Jul 31, 2012 | -35,161.00 |
| Apr 30, 2012 | 33,336.00 |
| Apr 30, 2012 | 33,336.00 |
| Jan 31, 2012 | -20,987.00 |
| Jan 31, 2012 | -20,987.00 |